Literature DB >> 2767220

Immunologic memory induced at birth by immunization with inactivated polio vaccine in a reduced schedule.

T A Swartz1, R Handsher, P Stoeckel, J Drucker, P Caudrelier, A L Van Wezel, H Cohen, D Salk, J Salk.   

Abstract

One hundred forty-one healthy newborns were immunized 24 hours after birth with one dose of inactivated polio vaccine (IPV) of enhanced potency. Following the administration of a second vaccine dose six months later, a considerable proportion of babies responded with neutralizing antibody (NA) to the three poliovirus types. The very rapid occurrence and high antibody titer were indicative of an anamnestic response. Twenty-one infants who still had NA less than 1:4 to one-more poliovirus types after the second vaccine dose responded with very high NA values 7-10 days after a supplementary dose of IPV. It appears that IPV of enhanced potency administered at birth is apt to induce immunologic memory, which should provide the basis for protection against paralytic poliomyelitis in case of exposure to wild poliovirus later in life.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767220     DOI: 10.1007/BF00156819

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  7 in total

1.  Immune response of infants in tropics to injectable polio vaccine.

Authors:  R Krishnan; M Jadhav; R Selvakumar; T J John
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-16

2.  Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.

Authors:  F Assaad
Journal:  Dev Biol Stand       Date:  1981

Review 3.  Control of poliomyelitis: a continuing paradox.

Authors:  D M Horstmann
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

4.  Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries.

Authors:  F M LaForce; M S Lichnevski; J Keja; R H Henderson
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

5.  One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine.

Authors:  J Salk
Journal:  Rev Infect Dis       Date:  1984 May-Jun

6.  A controlled trial with inactivated poliovaccine.

Authors:  T A Swartz; E Ben-Porath; Z Ben-Yshai; Z Weissmann; A Kanaaneh; L Leitner; N Goldblum
Journal:  Dev Biol Stand       Date:  1981

7.  Poliomyelitis vaccines: killed or live?

Authors: 
Journal:  Br Med J       Date:  1978-09-23
  7 in total
  9 in total

Review 1.  Nanoparticle systems for cancer vaccine.

Authors:  Ru Wen; Afoma C Umeano; Yi Kou; Jian Xu; Ammad Ahmad Farooqi
Journal:  Nanomedicine (Lond)       Date:  2019-02-26       Impact factor: 5.307

Review 2.  Oral and inactivated poliovirus vaccines in the newborn: a review.

Authors:  Farrah J Mateen; Russell T Shinohara; Roland W Sutter
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

3.  Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Authors:  E Bellelli; M L Tanzi; V Bocelli; U Bracchi; P Affanni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

4.  Seroconversion following killed polio vaccine in neonates.

Authors:  P K Jain; A K Dutta; S Nangia; S Khare; A Saili
Journal:  Indian J Pediatr       Date:  1997 Jul-Aug       Impact factor: 1.967

5.  Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shortly after birth.

Authors:  N Linder; R Handsher; B German; L Sirota; M Bachman; S Zinger; E Mendelson; A Barzilai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

6.  Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya.

Authors:  P W Kok; J Leeuwenburg; P Tukei; A L van Wezel; J G Kapsenberg; G van Steenis; A Galazka; S E Robertson; D Robinson
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

7.  Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial.

Authors:  Xavier Sáez-Llorens; Ralf Clemens; Geert Leroux-Roels; José Jimeno; Sue Ann Costa Clemens; William C Weldon; M Steven Oberste; Natanael Molina; Ananda S Bandyopadhyay
Journal:  Lancet Infect Dis       Date:  2015-12-21       Impact factor: 71.421

Review 8.  Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis.

Authors:  Nicholas C Grassly
Journal:  J Infect Dis       Date:  2014-03-14       Impact factor: 5.226

9.  Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.

Authors:  Siddhartha Kumar Bhaumik; Raveendra R Kulkarni; William C Weldon; Eduardo L V Silveira; Hasan Ahmed; Sivaram Gunisetty; Anmol Chandele; Rustom Antia; Harish Verma; Roland Sutter; Mark A Pallansch; M Steven Oberste; Francois Villinger; Walter Orenstein; Kaja Murali-Krishna
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.